CSP Lam, A Lyass, E Kraigher-Krainer… - Circulation, 2011 - Am Heart Assoc From the National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, MA (CSL, AL, JM, DSL, JEH, DL, EJB, RSV); Department of Mathematics and Statistics, Boston University, Boston, MA (AL); Department of Cardiology, University of Graz, Graz, Austria ... Cited by 2 - Related articles - All 3 versions
M Hoshijima, T Hayashi, YE Jeon, Z Fu… - Circulation: Heart …, 2011 - Am Heart Assoc Methods and Results— We treated 4-month-old BIO14.6 hamsters with established cardiac and skeletal muscle diseases intravenously with a serotype-9 adeno–associated viral vector carrying δSG alone or in combination with S16EPLN. Before treatment at age 14 weeks, the left ... Cited by 1 - Related articles - All 3 versions
MMY Sung, DPY Koonen, CLM Soltys… - Journal of molecular …, 2011 - Springer Abstract As aging is a significant risk factor for the development of left ventricular hypertrophy and cardiovascular disease, we hypothesized that hearts from middle-aged mice may be more sensitive to the effects of a high fat (HF) diet than hearts from young ... Cited by 1 - Related articles - All 4 versions
J James, K Kinnett, Y Wang, RF Ittenbach… - Neuromuscular …, 2011 - Elsevier Overt cardiac involvement in Duchenne muscular dystrophy (DMD) typically occurs later in the disease. The primary aim was to estimate the proportion of young (<6 years of age) DMD patients with manifestations of cardiac disease by electrocardiography (ECG). Secondary aims ... Related articles - All 3 versions
[HTML] from nih.govMS Ewer, SM Swain, D Cardinale… - Texas Heart Institute …, 2011 - ncbi.nlm.nih.gov The recognition of cardiac dysfunction as a consequence of cancer treatment was much simpler when anthracycline cardiotoxicity was the dominant concern. We knew of the cumulative dose relationship as it applied to cardiac dysfunction; we knew that anthracyclines caused cell ... Related articles - All 2 versions
CSP Lam, A Lyass, E Kraigher-Krainer… - Circulation, 2011 - Am Heart Assoc From the National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, MA (CSL, AL, JM, DSL, JEH, DL, EJB, RSV); Department of Mathematics and Statistics, Boston University, Boston, MA (AL); Department of Cardiology, University of Graz, Graz, Austria ... Cited by 2 - Related articles - All 3 versions
M Hoshijima, T Hayashi, YE Jeon, Z Fu… - Circulation: Heart …, 2011 - Am Heart Assoc Methods and Results— We treated 4-month-old BIO14.6 hamsters with established cardiac and skeletal muscle diseases intravenously with a serotype-9 adeno–associated viral vector carrying δSG alone or in combination with S16EPLN. Before treatment at age 14 weeks, the left ... Cited by 1 - Related articles - All 3 versions
MMY Sung, DPY Koonen, CLM Soltys… - Journal of molecular …, 2011 - Springer Abstract As aging is a significant risk factor for the development of left ventricular hypertrophy and cardiovascular disease, we hypothesized that hearts from middle-aged mice may be more sensitive to the effects of a high fat (HF) diet than hearts from young ... Cited by 1 - Related articles - All 4 versions
J James, K Kinnett, Y Wang, RF Ittenbach… - Neuromuscular …, 2011 - Elsevier Overt cardiac involvement in Duchenne muscular dystrophy (DMD) typically occurs later in the disease. The primary aim was to estimate the proportion of young (<6 years of age) DMD patients with manifestations of cardiac disease by electrocardiography (ECG). Secondary aims ... Related articles - All 3 versions
[HTML] from nih.govMS Ewer, SM Swain, D Cardinale… - Texas Heart Institute …, 2011 - ncbi.nlm.nih.gov The recognition of cardiac dysfunction as a consequence of cancer treatment was much simpler when anthracycline cardiotoxicity was the dominant concern. We knew of the cumulative dose relationship as it applied to cardiac dysfunction; we knew that anthracyclines caused cell ... Related articles - All 2 versions
CSP Lam, A Lyass, E Kraigher-Krainer… - Circulation, 2011 - Am Heart Assoc From the National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, MA (CSL, AL, JM, DSL, JEH, DL, EJB, RSV); Department of Mathematics and Statistics, Boston University, Boston, MA (AL); Department of Cardiology, University of Graz, Graz, Austria ... Cited by 2 - Related articles - All 3 versions
M Hoshijima, T Hayashi, YE Jeon, Z Fu… - Circulation: Heart …, 2011 - Am Heart Assoc Methods and Results— We treated 4-month-old BIO14.6 hamsters with established cardiac and skeletal muscle diseases intravenously with a serotype-9 adeno–associated viral vector carrying δSG alone or in combination with S16EPLN. Before treatment at age 14 weeks, the left ... Cited by 1 - Related articles - All 3 versions
MMY Sung, DPY Koonen, CLM Soltys… - Journal of molecular …, 2011 - Springer Abstract As aging is a significant risk factor for the development of left ventricular hypertrophy and cardiovascular disease, we hypothesized that hearts from middle-aged mice may be more sensitive to the effects of a high fat (HF) diet than hearts from young ... Cited by 1 - Related articles - All 4 versions
J James, K Kinnett, Y Wang, RF Ittenbach… - Neuromuscular …, 2011 - Elsevier Overt cardiac involvement in Duchenne muscular dystrophy (DMD) typically occurs later in the disease. The primary aim was to estimate the proportion of young (<6 years of age) DMD patients with manifestations of cardiac disease by electrocardiography (ECG). Secondary aims ... Related articles - All 3 versions
[HTML] from nih.govMS Ewer, SM Swain, D Cardinale… - Texas Heart Institute …, 2011 - ncbi.nlm.nih.gov The recognition of cardiac dysfunction as a consequence of cancer treatment was much simpler when anthracycline cardiotoxicity was the dominant concern. We knew of the cumulative dose relationship as it applied to cardiac dysfunction; we knew that anthracyclines caused cell ... Related articles - All 2 versions
CSP Lam, A Lyass, E Kraigher-Krainer… - Circulation, 2011 - Am Heart Assoc From the National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, MA (CSL, AL, JM, DSL, JEH, DL, EJB, RSV); Department of Mathematics and Statistics, Boston University, Boston, MA (AL); Department of Cardiology, University of Graz, Graz, Austria ... Cited by 2 - Related articles - All 3 versions
M Hoshijima, T Hayashi, YE Jeon, Z Fu… - Circulation: Heart …, 2011 - Am Heart Assoc Methods and Results— We treated 4-month-old BIO14.6 hamsters with established cardiac and skeletal muscle diseases intravenously with a serotype-9 adeno–associated viral vector carrying δSG alone or in combination with S16EPLN. Before treatment at age 14 weeks, the left ... Cited by 1 - Related articles - All 3 versions
MMY Sung, DPY Koonen, CLM Soltys… - Journal of molecular …, 2011 - Springer Abstract As aging is a significant risk factor for the development of left ventricular hypertrophy and cardiovascular disease, we hypothesized that hearts from middle-aged mice may be more sensitive to the effects of a high fat (HF) diet than hearts from young ... Cited by 1 - Related articles - All 4 versions
J James, K Kinnett, Y Wang, RF Ittenbach… - Neuromuscular …, 2011 - Elsevier Overt cardiac involvement in Duchenne muscular dystrophy (DMD) typically occurs later in the disease. The primary aim was to estimate the proportion of young (<6 years of age) DMD patients with manifestations of cardiac disease by electrocardiography (ECG). Secondary aims ... Related articles - All 3 versions
[HTML] from nih.govMS Ewer, SM Swain, D Cardinale… - Texas Heart Institute …, 2011 - ncbi.nlm.nih.gov The recognition of cardiac dysfunction as a consequence of cancer treatment was much simpler when anthracycline cardiotoxicity was the dominant concern. We knew of the cumulative dose relationship as it applied to cardiac dysfunction; we knew that anthracyclines caused cell ... Related articles - All 2 versions